Skip to main content
padlock icon - secure page this page is secure
Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.

Publisher: Bentham Science Publishers

More about this publication?
Volume 8, Number 2, 2012

Articles

Open Access Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
pp. 118-134(17)
Authors: Soler-Ferran, Dulce; J. Briskin, Michael

Favourites:
ADD

Open Access The Discovery of CDP323, a Potent Alpha4 Integrin Antagonist
pp. 135-140(6)
Authors: Bailey, Stuart; Palframan, Roger; Watt, Gillian; Porter, John

Favourites:
ADD

Open Access Therapeutic Targeting of Chemokines with Monoclonal Antibodies
pp. 141-148(8)
Authors: L. de Graaf, Katrien; H. Kosco-Vilbois, Marie; Fischer, Nicolas

Favourites:
ADD
Favourites:
ADD

Open Access Phosphoinositide 3-Kinases and Leukocyte Migration
pp. 154-160(7)
Author: G. Ward, Stephen

Favourites:
ADD

Open Access Targeting Chemokines in Cancer
pp. 161-169(9)
Authors: Bonecchi, Raffaella; Savino, Benedetta; Mantovani, Alberto; Locati, Massimo

Favourites:
ADD

Open Access S1P Receptor Modulators in Cell Trafficking and Therapeutics
pp. 170-180(11)
Authors: J. Gonzalez-Cabrera, Pedro; M. Cahalan, Stuart; Ferguson, Jill; Rosen, Hugh

Favourites:
ADD

Open Access Pitfalls and Solutions for the Validation of Novel Drugs in Animal Models of Disease
pp. 181-189(9)
Authors: Johnson, Zoe; A. Power, Christine; E. I. Proudfoot, Amanda

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more